DJI45,960.11-1.01%
GDAXI22,612.97-1.50%
GSPC6,477.16-1.74%
HSI24,856.43-1.89%
IXIC21,408.08-2.38%
N22553,603.65-0.27%
AAPL252.89+0.11%
AMZN207.54-1.97%
CL93.44-1.10%
EURUSD1.1539-0.22%
GBPUSD1.3334-0.25%
GC4,401.20+0.57%
GOOG280.74-3.06%
JPM291.66-1.27%
META547.54-7.96%
MSFT365.97-1.37%
NVDA171.24-4.16%
TSLA372.11-3.59%
DJI45,960.11-1.01%
GDAXI22,612.97-1.50%
GSPC6,477.16-1.74%
HSI24,856.43-1.89%
IXIC21,408.08-2.38%
N22553,603.65-0.27%
AAPL252.89+0.11%
AMZN207.54-1.97%
CL93.44-1.10%
EURUSD1.1539-0.22%
GBPUSD1.3334-0.25%
GC4,401.20+0.57%
GOOG280.74-3.06%
JPM291.66-1.27%
META547.54-7.96%
MSFT365.97-1.37%
NVDA171.24-4.16%
TSLA372.11-3.59%
DJI45,960.11-1.01%
GDAXI22,612.97-1.50%
GSPC6,477.16-1.74%
HSI24,856.43-1.89%
IXIC21,408.08-2.38%
N22553,603.65-0.27%
AAPL252.89+0.11%
AMZN207.54-1.97%
CL93.44-1.10%
EURUSD1.1539-0.22%
GBPUSD1.3334-0.25%
GC4,401.20+0.57%
GOOG280.74-3.06%
JPM291.66-1.27%
META547.54-7.96%
MSFT365.97-1.37%
NVDA171.24-4.16%
TSLA372.11-3.59%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
USA Seeking Alpha EN

SpyGlass Pharma, Inc. GAAP EPS of -$5.72

Mar 26, 2026 &03392626202631; 20:39 UTC seekingalpha.com Trending 3/5
Read original on seekingalpha.com ↗
↘
Negative for markets
Sentiment score: -65/100
Low impact Short-term (days)
WHAT THIS MEANS
SpyGlass Pharma reported a significant GAAP loss of -$5.72 per share, indicating substantial operational challenges. However, this is a micro-cap biotech with minimal market impact; the broader S&P 500 decline (-1.74%) and VIX spike (+8.33%) are driven by macro factors, not this single earnings miss.
AI CONFIDENCE
35% Low
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
↓
SPYG
SPYGStock
Expected to decline
Large negative EPS (-$5.72) signals cash burn and operational losses; typical biotech sell-off on earnings miss. However, micro-cap liquidity is poor and stock may already have gapped down at open.
↓
S&P 500
^GSPCIndex
Expected to decline
S&P 500 already down -1.74% on macro headwinds; SpyGlass earnings are noise relative to broader market decline.
↑
VIX
VIXIndex
Expected to rise
Fear gauge spiking (+8.33%) reflects systemic risk, not biotech earnings. Macro volatility dominates.
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
SpyGlass is a micro-cap with poor liquidity; avoid trading on this earnings miss. The real story is the macro selloff (S&P -1.74%, VIX +8.33%). If trading biotech, focus on larger-cap names with better technicals and liquidity. Confidence is low due to illiquidity and unclear market absorption timing. [MOVE:2.5%]
KEY SIGNALS
Large negative EPS (-$5.72) indicates cash burnMicro-cap biotech with limited institutional followingBroader market decline (-1.74% S&P 500) suggests macro headwinds, not stock-specific catalystVIX spike (+8.33%) indicates systemic risk environment
SECTORS INVOLVED
HealthcareBiotechnology
Analysis generated on Mar 26, 2026 at 20:45 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

Duke Energy wins regulator's approval for new South Carolina gas generation plant
Seeking Alpha Mar 26, 22:17 Positive
Venture Global settles Calcasieu Pass arbitration dispute with Italy's Edison
Seeking Alpha Mar 26, 22:06 Positive
Innovate outlines $1.8B adjusted backlog growth and regulatory milestones as company advances restructuring
Seeking Alpha Mar 26, 22:06 Neutral
Datacentrex prices $20.17M stock offering; shares down
Seeking Alpha Mar 26, 21:59 Negative
RH appoints David Stanchak as chief real estate and transformation officer
Seeking Alpha Mar 26, 21:56 Neutral